跳至主要内容
临床试验/NCT01768078
NCT01768078已完成3 期

Interest of Intravitreal Corticotherapy as the First-line Treatment for Post-operative Endophthalmitis.

Centre Hospitalier Universitaire Dijon10 个研究点 分布在 1 个国家目标入组 112 人开始时间: 2008年9月最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
入组人数
112
试验地点
10
主要终点
Measure the evolution of visual acuity

研究概览

简要总结

One useful effect of early intravitreal corticotherapy is to diminish inflammatory complications after endophthalmitis, which may cause, at least in part, serious complications (retinal detachment, macular edema) which are, more than the infection, causes of the complications seen after acute endophthalmitis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

性别
All
接受健康志愿者

入选标准

  • All patients male or female with no age limit
  • Hospitalized for the diagnosis and treatment of acute endophthalmitis following cataract surgery
  • Who had given their consent after being informed about intravitreal corticotherapy

排除标准

  • Patients who refused or were unable to give their consent
  • Prior intravitreal corticotherapy

研究组 & 干预措施

with corticoids

Experimental

干预措施: Intravitreal injection of Betamethasone + antibiotics (Procedure)

without corticoids

Other

干预措施: Intravitreal injection of antibiotics (Procedure)

结局指标

主要结局

Measure the evolution of visual acuity

时间窗: up to12 months

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验

Interest of Intravitreal Corticotherapy as the... | 临床试验